Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2019

Feb 12, 2019

34595_dirs_2019-02-12_314cba8f-a105-481f-aff5-91e4f15bccea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-02-08

Reporting Person: Blumhoff Jill (VP, Finance & CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-08 Employee Stock Option (right to buy) $1.42 A 25000 Acquired 2029-02-08 Common Shares (25000) Direct

Footnotes

F1: The option becomes exercisable with respect to 40% of the shares on the first anniversary of the date of grant and with respect to an additional 30% of the shares on each of the second anniversary and the third anniversary of the date of grant, respectively.